Express Scripts To Cover Pricey New Cholesterol Treatments

Express Scripts To Cover Pricey New Cholesterol Treatments

The nation’s biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year.

Express Scripts said Tuesday that it will pay for prescriptions of Amgen Inc.’s Repatha as well as Praluent from Sanofi and Regeneron Pharmaceuticals Inc. under a few conditions designed to control costs.

Read more at: http://bit.ly/1ZhdhCY